Rejuvenation of Stem cells by GSK-3 Inhibitor
Professor Mick Bhatia and his team from Robarts Research Institute have found that supplementation of GSK-3 Inhibitors with Cord blood regenerates the immune system to produce immune cells which fights against cancer cells.// Researchers have found that this drug GSK-3 which is used in the treatment of Alzheimer’s and diabetes to boost the immune cells without causing any toxicity or side effects...GSK’s New Anticancer Drug A Huge Success In Drug trail
Tykerb, the new experimental breast cancer treatment drug has proved so well in the drug trails, that based on its success alone the drug might be made //available to patients in the late stages of the disease even before it is approved by the regulators. ....It is speculated that Europe's largest drug maker is all set to dominate the world's biggest cancer conference in Atlanta today with infor...China to make cheaper version of GSK’s flu dru
GlaxoSmithKline signed an agreement with Simcere Pharmaceutical Group of Nanjing, China for it to manufacture and sell a cheaper version of its flu drug Relenza in poor countries//. ..The Chinese company can manufacture and sell zanamivir in China, Indonesia, Thailand, Vietnam and all least-developed countries, under the terms of licensing agreement. .."GSK is doing everything we can to prepare...GSK Seeks Permission to Market Breast Cancer Pill Tykerb
..GlaxoSmithKline PLC has filed for permission with European medicine regulators to begin selling its new breast cancer pill Tykerb//. ....This follows a similar move in the US last month, and comes slightly earlier than some commentators were expecting. ....The drug is foreseen to be one of GSK's most promising pipeline drugs as well as a potential blockbuster. According to analysts at Nomura Co...GSK, TCS to Jointly Set Up Drug Development Center
Pharma major GlaxoSmithKline (GSK) and global IT giant Tata Consultancy Services (TCS) have entered //into a multi-million dollar contract for setting up a global drug development center in Mumbai. ....Under the contract, TCS will provide a variety of services in clinical research, including clinical data management and clinical submissions support. ...."GSK has chosen to partner with TCS b...Eurand and GSK Reach Development Milestone
Eurand N.V., a global specialty pharmaceutical company, announced today that Eurand, Inc. and its collaboration partner, GlaxoSmithKline (NYSE: GSK), reached a significant milestone in the development of an orally disintegrating tablet formulation of an undisclosed compound. ......GSK has started a registration bioequivalence study for the new formulation and will make a milestone payment of $1...FDA Grants Standard Review for GSK's Experimental HPV Vaccine Cervarix
GlaxoSmithKline on Thursday announced that FDA has granted a standard 10-month review of its experimental human papillomavirus vaccine Cervarix, Reuters reports. A GSK spokesperson on Thursday said FDA declined to grant priority review, which could have been completed in six months. ......Cervarix and Merck's HPV vaccine Gardasil have been shown to be 100% effective in preventing infection with...